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Abstract
The effects of aging on glutamate neurotransmission in the brain is reviewed and
evaluated. Glutamate is the neurotransmitter in most of the excitatory synapses and appears
to be involved in functions such as motor behaviour, cognition and emotion, which alter
with age. However, relatively few studies have been conducted to study the relationship
between glutamate and aging of the brain. The studies presented here indicate the existence
of a number of changes in the glutamatergic system during the normal process of aging.
First, an age-related decrease of glutamate content in tissue from cerebral cortex and
hippocampus has been reported, although it may be mainly a consequence of changes in
metabolic activity rather than glutamatergic neurotransmission. On the other hand, studies
in vitro and in vivo have shown no changes in glutamate release during aging. Since
glutamate sampled in most of these studies is the result of a balance between release and
uptake processes, the lack of changes in glutamate release may be due to compensatory
changes in glutamate uptake. In fact, a reduced glutamate uptake capacity, as well as a loss
in the number of high affinity glutamate transporters in glutamatergic terminals of aged rats,
have been described. However, the most significant and consistent finding is the decrease in
the density of glutamatergic NMDA receptors with age. A new perspective, in which
glutamate interacts with other neurotransmitters to conform the substrates of specific circuits
of the brain and its relevance to aging, is included in this review. In particular, studies from
our laboratory suggest the existence of age-related changes in the interaction between
glutamate and other neurotransmitters, e.g. dopamine and GABA, which are regionally
specific. © 2001 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Aging could be defined as a process of progressive degeneration of an organism.
Behaviourally, aged animals show impairments in cognitive (learning and memory),
emotional (motivation) and motor functions (Jolles, 1986), alterations that are the
consequence of changes that occur in the brain with age. Changes in aged brains
include shrinkage and loss of neurons in several areas, such as the neocortex,
hippocampus and substantia nigra (Coleman and Flood, 1987). Also, at the
beginning of the aging process, dendritic growth (perhaps as a compensatory
response to the degeneration of neighbouring neurons) has been described, followed
by regression at older ages (Coleman and Flood, 1987). These morphological
changes, accompanied by changes in neurotransmission, may explain the altered
brain function that occurs during aging. Neurochemical studies have shown
changes in cholinergic (Bartus et al., 1982), catecholaminergic (Roth et al., 1986;
Morgan et al., 1987; Govoni et al., 1988) and peptidergic (Fliers and Swaab, 1986)
neurotransmission with age. However, very few studies have investigated glutamate
neurotransmission during aging. This review focuses on the effects of aging on
glutamate content in brain tissue and glutamate neurotransmission in the brain,
highlighting the age-related changes in glutamate interactions with other
neurotransmitters.
2. Glutamate neurotransmission
Glutamate is the neurotransmitter that acts in most of the excitatory synapses in
the mammalian central nervous system (CNS) (Fonnum, 1984; Orrego and Vil-
lanueva, 1993). Glutamatergic neurons are widely distributed through the CNS,
mainly in the forebrain, where most of the cortical projections contain glutamate
(Fagg and Foster, 1983; Cotman et al., 1987). In particular, the cortico-striatal and
the cortico-cortical (hipoccampus, commisure) pathways have been extensively
studied (Fagg and Foster, 1983; Peinado and Mora, 1986; Cotman et al., 1987)
(Fig. 1).
The metabolism of glutamate in the brain is separated into two compartments:
neuronal and glial (Fig. 2). The synthesis of glutamate occurs mainly from
glutamine through the action of glutaminase, which is localized in the mitocondria
of glutamatergic terminals (Fonnum, 1993). Regarding the catabolism of glutamate,
the glial enzyme glutamine synthetase converts glutamate to glutamine (Norenberg
and Martı́nez-Hernández, 1979; Fonnum, 1993). Thus, glutamate released from
neurons is transported to glial cells where it is converted into glutamine, which, in
turn, diffuses through the extracellular space into neurons to be used for the
synthesis of glutamate.
Exocitotic calcium-dependent release of glutamate has been demonstrated in both
in vitro and in vivo preparations (Fonnum, 1984; Nicholls, 1993; Sanchez-Prieto et
al., 1994; Zilkha et al., 1995) (Fig. 2). Recent studies have shown that, as well as
neurons, astrocytes can release glutamate and therefore, be actively involved in
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glutamatergic neurotransmission (see review in Araque et al., 1999). Once released,
glutamate may reach a very high concentration in the synaptic cleft (1–3 mM)
(Clements, 1996), which allows the action of glutamate on postsynaptic receptors
and, in certain circumstances, the spillover and diffusion of glutamate to act on
extrasynaptic receptors (located perisynatically, in neighbouring synapses or in glial
cells) (see review in Kullmann and Asztely, 1998) (Fig. 2). High-affinity glutamate
transporters, located mainly in astrocyte processes surrounding glutamatergic ter-
minals (Gegelashvili and Schousboe, 1998; Seal and Amara, 1999), seem to play a
very important role in regulating the diffusion and therefore, the extrasynaptic
actions of glutamate (Asztely et al., 1997).
These high-affinity transporters located in astrocytes are the main mediators in
clearing of extracellular glutamate (Rothstein et al., 1996; Gegelashvili and Schous-
boe, 1998; Seal and Amara, 1999) (Fig. 2). The concentration of glutamate in the
extracellular space of the brain is low (0.1–1 mM), which is not surprising because
of the neurotoxic potential of glutamate (see e.g. Choi, 1988; Meldrum and
Garthwaite, 1990); this neurotoxicity of glutamate, however, has been recently
questioned (Obrenovitch and Urenjak, 1997). Five high affinity transporters of
glutamate have been cloned which are dependent on sodium and potassium
gradients (Gegelashvili and Schousboe, 1998; Seal and Amara, 1999). When these
gradients are dissipated, the glutamate transporters could be reversed and the
extracellular concentration of glutamate increased; it has been suggested that this
calcium-independent release of glutamate may play a role in pathological circum-
stances, such as ischemia, although its involvement in the physiological release of
glutamate is questioned (Nicholls, 1993; Attwell et al., 1993).
Two types of receptors mediate the actions of glutamate: ionotropic and metabo-
tropic receptors (Sprengel and Seeburg, 1993; Hollmann and Heinemann, 1994;
Ozawa et al., 1998) (Fig. 2). The ionotropic glutamate receptors can be distin-
guished by their pharmacological and electrophysiological properties: the N-
Fig. 1. Schematic diagram of the main glutamatergic pathways in the rat brain. ACC, nucleus
accumbens; CX, cerebral cortex; HP, hippocampus; SN, substantia nigra; ST, striatum; TH, thalamus;
VTA, ventro tegmental area. Modified from Cotman et al. (1987).
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Fig. 2. Schematic representation of the processes related to the glutamate neurotransmission. (1)
Synthesis of glutamate (GLU) from glutamine (GLN) through the action of glutaminase (Gln-ase). (2)
Storing of glutamate into synaptic vesicles. (3) Exocitotic release of glutamate. (4) Glutamate activation
of its receptors (AMPA, AMPA receptors; KA, kainate receptors; mGluR, metabotropic receptors;
NMDA, NMDA receptors; R-ex, extrasynaptic receptors (ionotropic or metabotropic)). (5) Uptake of
glutamate through high affinity transporters located in astrocytes and presynaptic terminals. (6)
Synthesis of glutamine from glutamate through the action of glutamine sinthetase (Gln-s).
methyl-D-aspartate (NMDA) receptor, a channel highly permeable to Ca2+, and
the a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) and the
kainate receptor, which are Na+-permeable channels. NMDA receptors are
voltage-dependent channels and are highly regulated; they have been implicated in
plasticity (learning and memory). AMPA receptors are the main mediators of the
fast excitatory transmission by glutamate and their localization is similar to that of
NMDA receptors. The role of kainate receptors is uncertain but they participate in
the fast excitatory transmission. The metabotropic receptors exert their effects by
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means of G-protein-initiated biochemical events. Eight subtypes of metabotropic
receptors have been cloned, which mediate both excitatory and inhibitory actions of
glutamate (Ozawa et al., 1998).
3. Aging of brain glutamatergic system
It has been suggested that glutamate is involved in a number of cerebral
functions which become altered with age, such as learning and memory (see e.g.
Collindridge and Bliss, 1987; Cotman et al., 1988), emotion and motivation (Mora
and Cobo, 1990; Cobo and Mora, 1991) and motor functions (Schmidt et al., 1992).
Glutamate seems to be involved in the pathogenesis of several age-related neurode-
generative disorders including Huntington’s, Parkinson’s and Alzheimer’s diseases
(see Choi, 1988; Greenamyre and Young, 1989; Meldrum and Garthwaite, 1990;
Obrenovitch and Urenjak, 1997 for reviews). An increased susceptibility to gluta-
mate induced toxicity with age has also been described (Liu et al., 1996; Brewer,
1998), which may be due in part to a reduction in the concentration of antioxidants
(Vatassery et al., 1998; Lynch, 1998).
Studies on the aging of the brain are complicated by several confounding factors.
The most evident are those related to species, strains and individual variability of
the animals. For example, several reports have shown an age-related loss of neurons
in various cerebral areas in human and monkey, but not in the rodent (Coleman
and Flood, 1987). Also, differences between strains in how a particular parameter,
such as NMDA receptor density, undergoes a change with age have been described
(Petersen and Cotman, 1989). This variability is mainly due to the fact that
chronological age is not the best indicator of the aging process and no biological
markers are available to determine the onset of aging. So, in this review, to avoid
interspecies variability and since research on brain aging has been carried out
mainly in rodents, the results reported in the scientific literature obtained with
rodent brains are considered in the light of the limitations mentioned above.
Two methodological factors should be underlined. First, erroneous conclusions
could be drawn from studies that examined only two groups of age; studies on
aging should be performed using animals of several ages (Coleman and Flood,
1987). This recommendation circumvents the problem of differentiating maturation
and aging processes. Secondly, the brain is a heterogeneous organ with anatomi-
cally and physiologically different areas which may be affected in different manners
by the aging process. Studies examining the whole brain or large cerebral regions,
which include a number of heterogeneous areas, can complicate the interpretation
of data. All these factors are taken into account in the present review.
3.1. Brain glutamate content
Initial studies of the effects of aging on glutamatergic neurotransmission investi-
gated the content of glutamate in cerebral tissue samples from both origin and
destination areas of the glutamatergic pathways. Table 1 summarizes available data
for changes in glutamate content in brain tissue during aging.
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Several reports have shown a decrease in glutamate concentration in tissue
samples taken from the whole cerebral cortex of rodents as a result of age (Davis
and Himwich, 1975; Strolin-Benedetti et al., 1990, 1991; Saransaari and Oja, 1995).
The cerebral cortex is a heterogeneous structure and age-related changes in gluta-
mate content may occur at different rates in different areas. In fact, studies
performed in tissue samples of discrete areas of the cerebral cortex of Fischer-344
and Wistar rats show significant decreases in glutamate concentration in the frontal
region, by 15–20% at 21–24 months (Fornieles et al., 1986; Dawson et al., 1989;
Wallace and Dawson, 1990) but not in other areas, such as the parietal and
temporal cortices (Fornieles et al., 1986; Banay-Schwartz et al., 1989). It is
interesting that differences seem to exist between frontal areas. For instance, an
age-related decrease in glutamate has been reported in the medial prefrontal cortex
but not in the sulcal or dorsal prefrontal cortex (Fornieles et al., 1986). In contrast,
no significant changes in frontal glutamate content have been reported in other rat
strains (e.g. Long–Evans rats) in this same area of the brain (Dawson and Wallace,
1992). Since Long–Evans rats seem to have a longer life span (Coleman and Flood,
1987), it is possible that decreases could be found in glutamate in the frontal cortex
of this rat strain at older ages.
In the hippocampus of mice, Fisher-344 and Wistar rats, the glutamate content
in tissue samples seems to decrease with age (Banay-Schwartz et al., 1989; Strolin-
Benedetti et al., 1990, 1991; Saransaari and Oja, 1995). It is interesting that these
decreases in glutamate content have been consistently found at 12, 18, 21–24 and
29 months, reaching 6–8% in 21 months rats (Strolin-Benedetti et al., 1990, 1991)
and 23% in 29 months rats (Banay-Schwartz et al., 1989), whereas no changes in
glutamate with age have been reported in the hippocampus of Long–Evans rats
(Dawson and Wallace, 1992).
The decrease in glutamate content in the frontal cortex is in agreement with the
neuronal loss described in this area of the brain (Mufson and Stein, 1980) as well
as in the cerebral cortex of aged rodents (Knox, 1982; Heumann and Leuba, 1983;
Peters et al., 1987). The decrease in the glutamate content of the hippocampus also
agrees well with the age-related decrease in neuronal density reported in the CA1
and CA3 areas (Brizzee and Ordy, 1979; Landfield et al., 1981). Since glutamate is
the neurotransmitter of most cortical and hippocampal neurons (Fonnum, 1984),
the glutamate decrease in tissue samples from these structures could be interpreted
as a reflection of neuronal loss. Metabolic deficits in biochemical pathways that
generate or utilize glutamate as a substrate could also contribute to these decreases.
For example, changes in the regulation of glutaminase, the enzyme responsible for
the hydrolysis of glutamine to form glutamate and ammonia, have been described
in certain areas of the aged brain (Wallace and Dawson, 1992, 1993).
In rodent striatum, controversial results have been reported: a decrease of 15%
(Strolin-Benedetti et al., 1990, 1991), no changes (Wallace and Dawson, 1990;
Dawson and Wallace, 1992; Saransaari and Oja, 1995) and even increases (Don-
zanti and Ung, 1990) in glutamate content with age. Since the striatum is a
heterogeneous structure, these results could be related to the anatomical and
























Changes in glutamate content in brain tissue during aging
ReferencesAnimals Age (months) Changes UnitsBrain area
¡9%, PB0.05 mmoles/g wet tissue3 vs. 21–22 (Strolin-Benedetti et al., 1990)Wistar ratsWhole cerebral cortex
mmoles/g wet tissue (Strolin-Benedetti et al., 1991)Whole cerebral cortex Wistar rats 3 vs. 21–22 ¡10%, PB0.05
Whole cerebral cortex (Saransaari and Oja, 1995)mmoles/kg proteinNMRI mice ¡:30% at 12 months3, 6, 12, 18, 24
¡:30% at 18 months
¡:45% at 24 months,
PB0.01
¡16%, PB0.01Fischer-344 rats mmoles/g wet tissueFrontal cortex 6 vs. 24 (Dawson et al., 1989)
Fischer-344 rats (Wallace and Dawson, 1990)6 vs. 24 ¡18%, PB0.05Frontal cortex mmoles/g wet tissue
ng/mg protein (Donzanti and Ung, 1990)Medial prefrontal cortex Fischer-344 rats 6 vs. 20 Not significant
Wistar rats mmoles/g wet tissue (Fornieles et al., 1986)Medial prefrontal cortex 2, 12, 21 ¡9% at 12 months,
PB0.05
¡17% at 21 months,
PB0.05
mmoles/g wet tissue (Fornieles et al., 1986)Wistar ratsDorsal prefrontal cortex 2, 12, 21 Not significant
(Fornieles et al., 1986)mmoles/g wet tissueWistar rats Not significant2, 12, 21Sulcal prefrontal cortex
Wistar rats (Fornieles et al., 1986)2, 12, 21 Not significantTemporal cortex mmoles/g wet tissue
nmoles/mg protein (Banay-Schwartz et al., 1989)Occipital cortex Fischer-344 rats 3 vs. 29 Not significant
mmoles/g wet tissue (Strolin-Benedetti et al., 1990)3 vs. 21–22Hippocampus ¡6%, PB0.05Wistar rats
Hippocampus (Strolin-Benedetti et al., 1991)mmoles/g wet tissueWistar rats ¡8%, PB0.053 vs. 21–22
(Saransaari and Oja, 1995)NMRI mice 3, 6, 12, 18, 24 ¡:20% at 12 months mmoles/kg proteinHippocampus
¡:30% at 18 months
¡:15% at 24 months
(Banay-Schwartz et al., 1989)Fischer-344 rats 3 vs. 29 ¡23%, PB0.02 nmoles/mg proteinHippocampus
Hippocampus Fischer-344 rats 6 vs. 24 Not significant mmoles/g wet tissue (Wallace and Dawson, 1990)

























ReferencesAnimals Age (months) Changes UnitsBrain area
¡14%, PB0.01 mmoles/g wet tissue3 vs. 21–22 (Strolin-Benedetti et al., 1990)Wistar ratsStriatum
Wistar rats (Strolin-Benedetti et al., 1991)3 vs. 21–22 ¡15%, PB0.01Striatum mmoles/g wet tissue
NMRI mice (Saransaari and Oja, 1995)3, 6, 12, 18, 24 Not significantStriatum mmoles/kg protein
(Wallace and Dawson, 1990)Fischer-344 rats 6 vs. 21 Not significant mmoles/g wet tissueStriatum
ng/mg protein (Donzanti and Ung, 1990)Fischer-344 ratsStriatum anterior dorso medial 6 vs. 20 Not significant
ng/mg protein (Donzanti and Ung, 1990)Striatum anterior dorso lateral 6 vs. 20Fischer-344 rats  40%, PB0.05
Striatum anterior ventro lateral (Donzanti and Ung, 1990)ng/mg proteinFischer-344 rats  21%, PB0.056 vs. 20
(Donzanti and Ung, 1990)Fischer-344 rats 6 vs. 20 Not significant ng/mg proteinStriatum medial dorso medial
(Donzanti and Ung, 1990)Fischer-344 rats 6 vs. 20  35%, PB0.05 ng/mg proteinStriatum medial dorso lateral
ng/mg protein (Donzanti and Ung, 1990) 24%, PB0.05Striatum medial ventro lateral 6 vs. 20Fischer-344 rats
Not significant ng/mg protein (Donzanti and Ung, 1990)Striatum posterior dorso Fischer-344 rats 6 vs. 20
medial
(Donzanti and Ung, 1990)Fischer-344 rats ng/mg protein 18%, PB0.05Striatum posterior ventro 6 vs. 20
lateral
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Ung reported increases of 20–40% in the glutamate content in several striatal
subregions (dorsolateral and ventrolateral regions), but not in others (dorsomedial
regions) (Donzanti and Ung, 1990).
Few studies have investigated the effects of age on glutamate content in other
subcortical structures. In the nucleus accumbens, both decreases and no changes
have been described (Donzanti and Ung, 1990; Strolin-Benedetti et al., 1990, 1991).
In the substantia nigra, decreases (Strolin-Benedetti et al., 1990, 1991), no changes
(Banay-Schwartz et al., 1989) and increases (Donzanti and Ung, 1990) in glutamate
content have been reported.
In brief, the most consistent finding on the effects of aging on glutamate content
in tissue from different brain areas is a decrease in prefrontal cortex and in
hippocampus. It has been suggested that these data are related to the cognitive and
memory deficits reported to occur with age and attributed, at least in part, to
functions of the prefrontal cortex and hippocampus. However, since 70–80% of
tissue glutamate is present in the metabolic pool and only 20–30% in glutamatergic
nerve terminals (Fonnum, 1993), decreases in glutamate content may be mainly a
consequence of a change in metabolic activity. Whether or not these decreases in
glutamate content in prefrontal cortex and hippocampus are involved in be-
havioural deficits remains to be elucidated.
To investigate whether the effects of age on glutamatergic neurotransmission
occur in a given area of the brain, it is necessary to study both presynaptic and
postsynaptic markers, such as release, number of high-affinity uptake sites, trans-
port or receptor affinity, receptor density or postsynaptic effects, in cerebral
structures containing glutamatergic terminals. Studies of the effects of age on these
glutamatergic markers are reviewed below.
3.2. Glutamate release
Neurotransmitter release can be investigated using both in vitro and in vivo
techniques. The in vitro studies utilize brain slices or isolated nerve terminals
(synaptosomes) and analyze the content of glutamate in the superfusion medium.
These techniques provide the simplest model to investigate neurotransmitter release
(Nicholls, 1993; Sanchez-Prieto et al., 1994). In contrast, in vivo studies using
push–pull or microdialysis techniques, analyze the concentration of glutamate in
samples obtained from the extracellular space of a specific area of the brain
(Benveniste, 1989; Westerink and Justice, 1991; Porras and Mora, 1995; Segovia et
al., 1997). Data on changes in basal and induced glutamate release during aging are
summarized in Tables 2 and 3, respectively.
In the cerebral cortex, most of the in vitro and in vivo studies have shown no
significant changes in basal extracellular concentrations of glutamate during aging.
This remarkable stability of glutamate concentration seems to occur independently
of the areas (frontal, parietal and occipital cortices), species (rat and mouse) and
strains (Wistar, Long–Evans and Fischer-344 rats) (Dawson et al., 1989; Mora and
Cobo, 1991; Cobo et al., 1992 Dawson and Wallace, 1992; Palmer et al., 1994;
























Changes in basal glutamate release during aging
ReferencesAnimals Age (months) Changes TechniqueBrain area
Not significant In vitro (slices)6 vs. 28 (Dawson and Wallace, 1992)Fisher-344 ratsWhole cerebral cortex
(Saransaari and Oja, 1994)NMRI mice 3, 6, 12, 18, 24 Not significant In vitro (slices)Whole cerebral cortex
NMRI mice 3 vs. 24 (Saransaari and Oja, 1995)Not significant In vitro (slices)Whole cerebral cortex
(Palmer et al., 1994)Hybrid rats 3, 12, 24, 37 Not significant In vitro (slices)Neocortex
In vitro (slices) (Dawson et al., 1989)Fischer-344 ratsFrontal cortex 6 vs. 24 Not significant
In vivo (push–pull) (Cobo et al., 1992)Wistar ratsSulcal prefrontal cortex 3–4 vs. 24–26 Not significant
Wistar rats In vivo (push–pull)Not significantMedial prefrontal cortex 3–4 vs. 24–26 (Cobo et al., 1992)
Wistar rats (Cobo et al., 1993)3–4 vs. 28–30 Not significantMedial prefrontal cortex In vivo (push–pull)
In vivo (push–pull) (Porras et al., 1997)Wistar ratsMedial prefrontal cortex 2–3, 11–14, 24–26 Not significant
(Cobo et al., 1992)Wistar rats 3–4 vs. 24–26 Not significant In vivo (push–pull)Parieto-temporal cortex
8 vs. 28–30 In vitro (slices) (Meldrum et al., 1992)Temporal cortex Fischer-344 rats Not significant
Wistar rats (Cobo et al., 1992)3–4 vs. 24–26 Not significantOccipital cortex In vivo (push–pull)
In vitro (slices) (Freeman and Gibson, 1987)Hippocampus Balb/c mice 3 vs. 30  94%, PB0.05
In vitro (slices) (Saransaari and Oja, 1995)Hippocampus ¡:60%NMRI mice 3 vs. 24
(Meldrum et al., 1992)Fischer-344 rats 8 vs. 28–30 Not significant In vitro (slices)Hippocampus
Hippocampus (Massieu and Tapia, 1997)3 vs. 22–24  :68%,Wistar rats In vivo (microdialysis)
PB0.05
 77%, PB0.053 vs. 30 In vitro (slices)Balb/c miceStriatum (Freeman and Gibson, 1987)
In vitro (slices) (Saransaari and Oja, 1995)Striatum NMRI mice 3 vs. 24 Not significant
Striatum (Porras and Mora, 1995)In vivo (push–pull)Wistar rats Not significant2–3, 12–13, 24–34
(Corsi et al., 1997)Wistar rats 3, 12, 22 ¡40%, PB0.05 In vivo (microdialysis)Striatum
3 vs. 22–24 In vivo (microdialysis) (Massieu and Tapia, 1997)Striatum  :190%,Wistar rats
PB0.05
3 vs. 22 In vivo (microdialysis)Wistar ratsStriatum Not significant (Corsi et al., 1999)
(Segovia et al., 1999a)Wistar rats 2–3, 12–14, 27–32, 37 Not significant In vivo (microdialysis)Striatum
In vivo (microdialysis) (Donzanti et al., 1993)Lateral striatum Fischer-344 rats 4, 12, 18, 24–26  
In vivo (microdialysis) (Donzanti et al., 1993)Medial striatum 4, 12, 18, 24–26Fischer-344 rats Not significant
























Changes in induced glutamate release during aging
StimulationAnimals ReferencesAge (months) Changes TechniqueBrain area
K+ 50 mM (Saransaari and Oja, 1995) :50% In vitro (slices)3 vs. 24NMRI miceWhole cerebral
cortex
Not significant (Sanchez-Prieto et al., 1994)In vitro3 vs. 27–30Whole cerebral Wistar rats 4-aminopyridine 1
cortex mM(synaptosomes)
(Palmer et al., 1994)K+ 50 mMIn vitro (slices)Neocortex Not significantHybrid rats 3, 12–24, 37
Fischer-344 rats K+ 56 mM (Dawson et al., 1989)6 vs. 24 Not significantFrontal cortex In vitro (slices)
Electrical (Cobo et al., 1993)In vivo (push–pull)¡:50%,Medial prefrontal 3–4 vs. 28–30Wistar rats
cortex PB0.05
In vitro (slices)8 vs. 28–30 Electrical (Meldrum et al., 1992) :2-fold,Fischer-344 ratsTemporal cortex
PB0.05
(Freeman and Gibson, 1987)In vitro (slices)¡:80%3 vs. 30 K+Hippocampus Balb/c mice
K+ 50 mM (Saransaari and Oja, 1995)Hippocampus 3 vs. 24  :5-fold,NMRI mice In vitro (slices)
PB0.01
Electrical (Meldrum et al., 1992) :2-fold, In vitro (slices)8 vs. 28–30Fischer-344 ratsHippocampus
PB0.05
(Freeman and Gibson, 1987)In vitro (slices)¡66%, PB0.05 K+3 vs. 30Balb/c miceStriatum
NMRI mice In vitro (slices) K+ 50 mM (Saransaari and Oja, 1995)Striatum 3, 6, 12, 18, 24 ¡:30%,
PB0.01
4-Aminopyridine 1Striatum (Sanchez-Prieto et al., 1994)In vitroNot significant3 vs. 27–30Wistar rats
(synaptosomes) mM
In vivo3, 12, 22 K+ 100 mM (Corsi et al., 1997, 1999)Striatum Not significantWistar rats
(microdialysis)
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whole cerebral cortex induced by depolarizing agents, such as K+ or 4-aminopy-
ridine, seems to be unchanged with age (Dawson et al., 1989; Palmer et al., 1994;
Sanchez-Prieto et al., 1994). Only one study in vitro has reported an increase in the
release of glutamate induced by K+ up to 50% in aged versus young mice
(Saransaari and Oja, 1995).
As shown above, extracellular levels of glutamate did not change in the frontal
cortex during aging despite neuronal loss, which suggests that functional compensa-
tions are made by surviving neurons (Dawson et al., 1989; Mora and Cobo, 1991;
Cobo et al., 1992; Porras et al., 1997). However, a study from our laboratory
showed that electrical stimulation at intensities that release glutamate in young rats
does not increase glutamate in aged rats although the basal levels were similar in
both age groups (Cobo et al., 1993). This change could be due to a shift in the
excitability of the prefrontal cortex in old animals that could make the stimulation
intensity use a sub-threshold for influencing release. This is likely, since an increase
in the release of glutamate in the prefrontal cortex of aged rats was obtained with
an increase in the intensity of electrical stimulation. In any case, the study of Cobo
et al. suggests that neuronal changes, such as a decrease in excitability, do occur
with age in the prefrontal cortex of the rat (Cobo et al., 1993).
In the hippocampus, basal extracellular concentrations of glutamate in aged
rodents have been reported to be 94% greater (Freeman and Gibson, 1987), equal
(Meldrum et al., 1992) or 60% lower (Saransaari and Oja, 1995) compared with
those of adult rodents in in vitro studies. An in vivo study has reported an increase
of basal glutamate release in 24-month-old as compared with 3-month-old Wistar
rats (Massieu and Tapia, 1997). In potassium induced release of glutamate in aged
animals there are reports of no change (Freeman and Gibson, 1987) and of
increases by more than double (Meldrum et al., 1992; Saransaari and Oja, 1995).
In striatum, in vitro and in vivo studies have shown no changes in basal (Porras
and Mora, 1995; Saransaari and Oja, 1995; Corsi et al., 1999; Segovia et al., 1999a)
or chemically induced (Donzanti et al., 1993; Sanchez-Prieto et al., 1994; Corsi et
al., 1997, 1999) extracellular concentrations of glutamate in aged rats. In contrast,
there have been reports of both increases and decreases in the basal release of
glutamate in the striatum (Freeman and Gibson, 1987; Massieu and Tapia, 1997;
Corsi et al., 1997) and also a decrease in potassium induced relase of glutamate
(Freeman and Gibson, 1987; Saransaari and Oja, 1995). Interestingly, one study
described regional differences in age-related changes in basal extracellular concen-
trations of glutamate in striatum: an age-related increase in the extracellular
concentration of glutamate in the lateral, but not the medial striatum of rats
(Donzanti et al., 1993). It is possible that an actual increase in glutamate concentra-
tions in the lateral striatum could be hidden in the studies of the whole striatum.
These considerations are reinforced by the recent data of dopamine and GABA
obtained in the striatum using microdialysis, in which a clear regional difference
between dorsal and ventral striatum was found (Segovia et al., 1999a; Segovia,
1999).
To sum up, it might be said from the data revised above — in particular data
derived from synaptosomes studies — that no changes in glutamate release seem to
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occur during aging in cerebral cortex and striatum. However, the concentration of
glutamate sampled in most of these studies (slices, push–pull, microdialysis) is the
result of a balance between the release and uptake processes, so age-related
decreases in presynaptic release of glutamate may be compensated by changes in
uptake. On the other hand, push–pull and microdialysis techniques cannot differ-
entiate between neuronal or glial sources of glutamate, so the cellular origin of the
glutamate released is also uncertain (Timmerman and Westerink, 1997). Thus,
decreases in glutamate release from the neuronal compartment could be masked by
increases of glutamate release from non-neuronal sources.
3.3. Glutamate uptake
The main mechanism for clearing extracellular glutamate is the action of high-
affinity transporters located mainly in astrocyte processes surrounding glutamater-
gic terminals (Rothstein et al., 1996; Gegelashvili and Schousboe, 1998). Table 4
summarizes data on changes in glutamate uptake during aging.
In the cerebral cortex and striatum, studies show a reduced ability to take up
glutamate by aged rats (Wheeler and Ondo, 1986; Najerahim et al., 1990;
Saransaari and Oja, 1995; Vatassery et al., 1998). The magnitude of this decrease in
glutamate uptake with age has been averaged as 20–30% in rats at 24 months of
age. In mice, this decrease has been estimated at 70–80%. In agreement with these
findings, changes in the modulation by protein kinase C of the uptake of glutamate
have been also reported (Daniels and Vickroy, 1998). In contrast, other studies
have reported increases (Strong et al., 1984) or no changes (Dawson et al., 1989;
Palmer et al., 1994) in glutamate uptake.
Several reports indicate a decrease in the maximal velocity of glutamate uptake
(Price et al., 1981; Wheeler and Ondo, 1986). This could be interpreted as a loss in
the number of high-affinity glutamate transport sites in these brain areas. The
hippocampus exhibits a consistently unaltered uptake of glutamate during aging
(Gilad et al., 1990; Najerahim et al., 1990; Palmer et al., 1994).
As shown above, very few studies have addressed the effects of aging on
glutamate uptake, but most reported a lower uptake capacity for glutamate as well
as a loss in the number of high affinity glutamate transport sites in the glutamater-
gic terminals of aged rats in both striatum and prefrontal cortex (Price et al., 1981;
Wheeler and Ondo, 1986; Wheeler and Ondo, 1991; Najerahim et al., 1990;
Vatassery et al., 1998; Saransaari and Oja, 1995). This conclusion should be drawn
with caution when referred to its functional significance. That is, a decrease in the
number of transport sites in nerve terminals could be compensated by increases in
the affinity of the remaining sites (Price et al., 1981; Saransaari and Oja, 1995).
Moreover, glutamate is taken up mainly into glial cells (Rothstein et al., 1996;
Gegelashvili and Schousboe, 1998) and age-related changes in the uptake of
glutamate seem to occur mainly in neurons (Daniels and Vickroy, 1998). Since
astrocytes seem to increase in number and/or activity in the aging brain (Brizzee et
al., 1983; Terry, 1986; Vazquez et al., 1992; David et al., 1997), this could
























Changes in glutamate uptake during aging
Changes in affinity Technique ReferencesBrain area Age (months)Animals Changes in velocity
Synaptosomes (Daniels and Vickroy,5 vs. 37Forebrain ¡21% at 37 monthsHybrid rats
1998)
Synaptosomes2, 10, 18, 30 (Wheeler and Ondo,¡13% at 10 monthsLong–EvansWhole cerebral
cortex 1986)rats
¡21% at 18 months
 6–11%¡21% at 30 months
 41% at 18 months,NMRI mice 3, 6, 12, 18, 24Whole cerebral Synaptosomes (Saransaari and Oja,
1995)PB0.01cortex
 71% at 24 months,¡83% at 24 months,
PB0.01 PB0.01
TissueNeocortex (Najerahim et al., 1990Wistar rats 4, 12, 24 ¡22%, PB0.05
homogenate
(Palmer et al., 1994)Not significant Slices3, 12, 24, 37Neocortex Hybrid rats
Fischer-344 Slices (Dawson et al., 1989)6 vs. 24 Not significantFrontal cortex
rats
Wistar rats Tissue4, 12, 24 (Najerahim et al., 1990)Not significantHippocampus
homogenate




(Palmer et al., 1994)Not significant Slices3, 12, 24, 37Hippocampus Hybrid rats

























Changes in affinity Technique ReferencesBrain area Age (months)Animals Changes in velocity
¡46% at 19 mo  36% at 19 months
¡29% at 12 mo (Najerahim et al., 1990)TissueStriatum 4, 12, 24Wistar rats
homogenate
Not significant at 24
months
SlicesHybrid rats (Palmer et al., 1994)3, 12, 24, 37 Not significantStriatum
¡116% at 17 months, 84% at 17 months, Synaptosomes (Strong et al., 1984)Striatum, rostral Sprague–Dawley 7, 17, 27
PB0.05PB0.05rats
¡102% at 27 months, 79% at 27 months,
PB0.05PB0.05
¡105% at 17 months,Sprague–Dawley 7, 27 Synaptosomes (Strong et al., 1984)Not significantStriatum, caudal
rats PB0.05
Not significant at 27
months
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cortical slices, which include glial elements, reported no change in glutamate uptake
with age (Dawson et al., 1989).
3.4. Glutamate receptors
Two types of receptors mediate the depolarizing action of glutamate: ionotropic
and metabotropic receptors (Sprengel and Seeburg, 1993; Hollmann and Heine-
mann, 1994). Table 5 gives data on changes in glutamate receptors during aging.
A decrease with age in the density of glutamatergic receptors of the NMDA type
has been reported. This is probably one of the most consistent findings in relation
to glutamate and aging of the brain. Decreased NMDA receptor density has been
described in most of the cortical areas, striatum and hippocampus (Petersen and
Cotman, 1989; Miyoshi et al., 1990; Tamaru et al., 1991; Wenk et al., 1991; Cohen
and Müller, 1992; Magnusson and Cotman, 1992, 1993; Cimino et al., 1993;
Castorina et al., 1994; Serra et al., 1994; Nicolle et al., 1996; Wardas et al., 1997;
Mitchell and Anderson, 1998). The magnitude of this decrease is consistently
reported as between 20 and 50%. The decrease has been reported in several species
(rats and mice) and strains of rodents (Wistar and Fischer-344 rats; BALB/c,
C57B1 and NMR1 mice), independently of the binding assays used. In agreement
with the decrease in the NMDA receptor density, a decrease in NMDA receptor
mediated response has also been described in these cerebral structures (Baskys et
al., 1990; Gonzales et al., 1991; Cepeda et al., 1996). However, along with these
changes, an increase in the affinity of the NMDA receptor for glutamate (Cohen
and Müller, 1992) as well as changes in the influence of modulatory sites on the
NMDA receptor complex with age have also been reported (Miyoshi et al., 1990;
Piggott et al., 1992).
Decreases in glutamatergic AMPA receptor density have been reported in frontal
and parietal cortices of mice (Magnusson and Cotman, 1993), but not in the
cerebral cortex of rats (Tamaru et al., 1991; Cimino et al., 1993). In the hippocam-
pus, different subregions seem to change differently with age. Thus, an age-related
decrease in AMPA receptor density has been reported in certain, but not all areas
of the hippocampus (Cimino et al., 1993; Magnusson and Cotman, 1993), although
one study described no changes in the different subregions of the hippocampus
(Nicolle et al., 1996). In accordance with the decrease in AMPA receptor density
described in the CA1 area of the hippocampus (Magnusson and Cotman, 1993),
there is also a decrease in depolarization in response to AMPA application in this
area of the brain (Barnes et al., 1992).
Of interest is a recent report showing that the decrease of NMDA and AMPA
receptors in the hippocampus was significantly correlated with age-related declines
in learning (Magnusson, 1998).
Regarding the glutamatergic kainate receptor, there have been reports of both
decreases (Magnusson and Cotman, 1993) and no changes (Tamaru et al., 1991;
Nicolle et al., 1996) in the density of kainate binding with age in the cerebral cortex
and the hippocampus of the rat. Binding to glutamatergic metabotropic receptors
























Changes in glutamate receptors during aging
Animals ReferencesAge (months) ReceptorBrain area Changes
NMDA ¡29% in density, PB0.012, 7, 29 (Tamaru et al., 1991)Fischer-344 ratsWhole cerebral cortex
Not significant in affinity
¡13–23%, PB0.052, 6, 12, 18, 24 (Cimino et al., 1993)Whole cerebral cortex NMDAWistar–Kyoto rats
NMR1 mice (Cohen and Müller, 1992)3 vs. 20 NMDAForebrain ¡33% in density, PB0.001
 4-fold in affinity, PB0.01
¡:40%, PB0.01 (Wenk et al., 1991)Anterior cortex Fischer-344 rats 5 vs. 24 NMDA
(Wenk et al., 1991)¡:60%, PB0.015 vs. 24Fischer-344 rats NMDAPosterior cortex
Fischer-344 rats (Miyoshi et al., 1990)2, 5, 13, 21 NMDAFrontal cortex ¡60%, PB0.01
¡:30%, PB0.01 (Magnusson and Cotman, 1992)Frontal cortex C57131/6Nia mice 3, 10, 30 NMDA
Balb/c mice (Magnusson and Cotman, 1993)3 vs. 30 NMDAFrontal cortex ¡
Frontal cortex (Castorina et al., 1994)¡39% in density, PB0.01Fischer-344 rats NMDA4 vs. 24
Not significant in affinity
¡51%, PB0.01 (Miyoshi et al., 1990)Parietal cortex NMDAFischer-344 rats 2, 5, 13, 21
(Magnusson and Cotman, 1992)C57B1/6Nia mice 3, 10, 30 NMDA ¡:35%, PB0.01Parietal cortex
Parietal cortex Balb/c mice 3 vs. 30 NMDA ¡ (Magnusson and Cotman, 1993)
(Magnusson and Cotman, 1992)Not significantNMDAOccipital-temporal cortex 3, 10, 30C57B1/6Nia mice
¡47–51% (Miyoshi et al., 1990)Hippocampus Fischer-344 rats 2, 5, 13, 21 NMDA
Hippocampus (Castorina et al., 1994)¡26% in density, PB0.001Fischer-344 rats NMDA4 vs. 24
Not significant in affinity
(Magnusson and Cotman, 1992)C57B1/6Nia mice 3, 10, 30 NMDA ¡:10–20%, PB0.01Hippocampus
NMDA (Tamaru et al., 1991)¡24% in density, PB0.012, 7, 29Hippocampus Fischer-344 rats
Not significant in affinity
¡:50%, PB0.01 (Wenk et al., 1991)Fischer-344 ratsHippocampus 5 vs. 24 NMDA
Hippocampus Long–Evans rats 4 vs. 24–25 NMDA Not significant (Nicolle et al., 1996)
(Miyoshi et al., 1990)¡67%, PB0.01Striatum Fischer-344 rats NMDA2, 5, 13, 21
























Changes ReferencesBrain area Age (months)Animals Receptor
¡35% in density, PB0.001 (Castorina et al., 1994)Fischer-344 ratsStriatum 4 vs. 24 NMDA
Not significant in affinity
¡43%, PB0.05 (Nicolle et al., 1996)Long–Evans ratsStriatum 4 vs. 24–25 NMDA
C57B1/6Nia mice (Magnusson and Cotman, 1992)3, 10, 30 NMDAStriatum (caudate) ¡:40%, PB0.01
(Wenk et al., 1991)Fischer-344 rats 5 vs. 24 NMDA ¡:50%, PB0.01Striatum (caudate)
Not significant (Tamaru et al., 1991)Fischer-344 ratsWhole cerebral cortex 2, 7, 29 AMPA
Not significant (Cimino et al., 1993)2, 6, 12, 18, 24Whole cerebral cortex AMPAWistar–Kyoto rats
(Cimino et al., 1993)Not significantAMPAHippocampus (CA 1) 2, 6, 12, 18, 24Wistar–Kyoto rats
Wistar–Kyoto rats (Cimino et al., 1993)2, 6, 12, 18, 24 AMPAHippocampus (CA 3) ¡16–29%, PB0.05
(Cimino et al., 1993)Wistar–Kyoto rats 2, 6, 12, 18, 24 AMPA ¡16–25%, PB0.05Hippocampus (dentate gyrus)
Long–Evans rats Not significant (Nicolle et al., 1996)AMPAHippocampus 4 vs. 24–25
Not significant (Cimino et al., 1993)Striatum 2, 6, 12.,18, 24Wistar–Kyoto rats AMPA
(Nicolle et al., 1996)Not significantHippocampus 4 vs. 24–25Long–Evans rats Kainate
(Tamaru et al., 1991)Fischer-344 rats 2, 7, 29 Kainate Not significantHippocampus
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responses mediated by these receptors remained unaltered in the hippocampus of
aged animals (Jouvenceau et al., 1997).
In contrast to the reported decrease in the density of NMDA and AMPA
receptors in cortex and hippocampus, several electrophysiological studies have
described no changes in neuronal sensitivity to iontophoretic applications of
glutamate with age in these areas of the brain (Lippa et al., 1981; Rao et al., 1993;
Abdulla et al., 1995). This could be due to an increase of the affinity of glutamate
for its receptors that compensates for the decrease in the number of receptors. In
striatum, however, there are reports of a decrease of the neuronal responsiveness to
glutamate (Cepeda and Levine, 1991; Cepeda et al., 1996).
3.5. Summary of the effects of aging on brain glutamatergic system
Several conclusions could be drawn from the data reviewed here on the effects of
aging on brain glutamatergic system. First, most of the in vitro and in vivo studies
on basal and stimulated release of glutamate in the cerebral cortex, hippocampus
and striatum show no changes during aging, which suggests that the potentiality of
glutamatergic terminals to release glutamate is unaltered. However, the stability of
the release of glutamate should be interpreted with caution, since the concentration
of glutamate sampled in most of the studies (slices, push–pull, microdialysis) is the
result of a balance between the release and uptake processes. Thus, the reported
age-related decrease in the capacity of glutamate uptake in glutamatergic terminals
may compensate for changes in glutamate release. Moreover, the increase in the
number and/or activity of astrocytes during aging is a confounding factor which
could obscure the significance of the changes in glutamate release and uptake.
Second, a consistent decrease in the number of glutamatergic receptors, mainly of
the NMDA type, occurs in most of the cerebral areas of aged rodents, the
magnitude of this decrease being estimated at 20–50%. This effect of aging on
glutamatergic receptors would suggest that changes occur in glutamate neurotrans-
mission in the brain.
4. Interactions of glutamate with other neurotransmitter systems
Over 30 years ago, clinical data suggested the existence of a balance or interac-
tion between dopamine and acetylcholine as the basis of striatal functions (Barbeau,
1962), but this type of interaction was revised after the finding that glutamate also
interacts with dopamine in this area of the brain (see e.g. Giorguieff et al., 1997).
Since then, the concept of a complex reciprocal modulation of neural transmission
among a number of neurotransmitters, including glutamate, dopamine, acetyl-
choline, GABA and neuropeptides, has emerged to give a better understanding of
the physiology of specific circuits of the brain (Di Chiara et al. 1994; Mora et al.,
1999). Although the nature of these reciprocal interactions among neurotransmit-
ters in areas of the brain, such as prefrontral cortex and striatum, is not well
understood, its dysfunction has been implied in drug addiction and in several
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neurological disorders such as Parkinson’s disease and schizophrenia (Carlsson
and Carlsson, 1990; Grace, 1991; Greenamyre, 1993; Del Arco et al., 1998,
1999). Moreover, it has been suggested that a disruption in the fine adjustment
of these neurotransmitter interactions could be at the basis of the functional
decreases found during aging of the brain (Mora, 1991).
In recent years, several in vitro and in vivo studies have reported a decrease
or lack of the modulation by different neurotransmitters of stimulated glutamate
release in different areas of the brain during aging (Donzanti et al., 1993; Mur-
ray et al., 1997; Corsi et al., 1997). Thus, Donzanti et al. reported that activa-
tion of dopamine D2-receptor inhibits glutamate release evoked by potassium in
striatal synaptosomes of young Fisher-344 rats. In contrast, this inhibition of
glutamate release was not evoked in 24 to 26-month-old rats (Donzanti et al.,
1993). In line with these results are those reported by Murray et al., who also
showed than in old rats (22 months of age) there is a lack of inhibition by
interleukin-1 of potassium-evoked release of glutamate in hippocampal synapto-
somes of young rats (Murray et al., 1997).
In an in vivo study in young Wistar rats, Corsi et al. (1997) reported that
potassium-evoked glutamate release in the striatum was potentiated by an
adenosine antagonist, effects which were no longer produced in old rats (22
months) (Corsi et al., 1997). In contrast, these same authors showed that the
effects of an adenosine agonist on basal and potassium-evoked glutamate release
did not change during aging (Corsi et al., 1999). An in vivo study in our
laboratory reported the loss in old (24 months) Wistar rats of the ability of
melatonin to evoke glutamate release when the dopamine system is activated
(Expósito et al., 1995).
Other studies have evaluated the effects of aging on the responses induced by
glutamate (Cepeda and Levine, 1991; Gonzales et al., 1991; Pazzagli et al., 1995;
Cepeda et al., 1996). A reduction was reported in aged Fischer-344 rats of the
ability of dopamine to modulate striatal neuron responses induced by cortical
stimulation in vivo (Cepeda and Levine, 1991) or activation of glutamatergic
receptors by NMDA or glutamate itself in vitro (Cepeda et al., 1996). Gonzales
et al. reported that dopamine release from striatal slices evoked by NMDA is
lower in aged (24–28 months) than in young (3–5 months) Fischer-344 rats
(Gonzales et al., 1991). In contrast, activation of metabotropic receptors in vivo
increased dopamine release in prefrontal cortex of aged rats (24 months) but had
no effect on young rats (3 months) (Pintor et al., 1998). An in vivo study also
reported that glutamate is responsible for much of the basal striatal adenosine in
old (20–22 months) but not in young (3 months) Wistar rats (Pazzagli et al.,
1995).
In a recent series of in vivo experiments, we investigated the effects of aging
on the glutamate–dopamine interaction in striatum and prefrontal cortex of
Wistar rats (Porras and Mora, 1995; Porras et al., 1997). Interaction of neuro-
transmitters in striatum and prefrontal cortex has been the focus of intensive
research (see e.g. Expósito et al., 1994; Sanz et al., 1997; Segovia et al., 1997;
Segovia and Mora, 1998, for reviews see Di Chiara et al., 1994; Lannes and
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Micheletti, 1994; Mora and Porras, 1994; Mora et al., 1999). These areas are of
relevance for studies of brain aging due to their involvement in motor functions
and in cognition, emotion and motivation, all of which deteriorate with age (see
e.g. Ingram, 1985; Murray and Waddington, 1991; Deptula et al., 1993). In our
studies, the intracerebral perfusion of a dopamine agonist, apomorphine, pro-
duced an increase of extracellular glutamate in striatum and prefrontal cortex of
young rats (2–3 months), whereas a decreased response of glutamate was ob-
tained in middle-aged (12–14 months) and aged (24–26 months) rats, which
suggests a deterioration in glutamate–dopamine interaction with age (Porras and
Mora, 1995; Porras et al., 1997). These data may be explained by the decrease in
the number of dopamine receptors or the alterations in dopamine receptor-medi-
ated responses (Joyce et al., 1986; Hyttel, 1987; Han et al., 1989; Morelli et al.,
1990; Murray and Waddington, 1991).
We have recently used an original approach to study in vivo the endogenous
interactions of glutamate with other neurotrasmitter systems in several areas of
the brain (Segovia et al., 1997, 1999a,b; Del Arco and Mora, 1999; Mora et al.,
1999, 2000). In young rats, intracerebral perfusion (microdialysis) of an inhibitor
of glutamate uptake increases the extracellular concentrations of endogenous
glutamate in a range that allowed a study of the synaptic and extrasynaptic
interactions of glutamate with dopamine and GABA. In striatum and nucleus
accumbens, the increase in endogenous glutamate produced a release of do-
pamine and GABA that was attenuated by antagonists of NMDA and AMPA/
kainate receptors (Segovia et al., 1997, 1999a; Segovia, 1999). Moreover, the
increases of glutamate were correlated with the increases of dopamine and
GABA (Segovia et al., 1997, 1999a). When these studies were extended to aging
(Segovia, 1999; Segovia et al., 1999a Mora et al., 2000), we found that the
effects of endogenous glutamate on dopamine and GABA in striatum did not
change during aging. On the contrary, in the nucleus accumbens, there was an
age-related reduction of the increases of dopamine produced by glutamate. The
effects of glutamate on GABA tended to be higher in the nucleus accumbens.
These findings suggest that the changes in glutamate/dopamine and glutamate/
GABA interaction during the normal process of aging show a dorso-ventral
pattern in the basal ganglia, with changes in the ventral (nucleus accumbens) but
not in the dorsal striatum (Segovia, 1999; Segovia et al., 1999a).
As shown above, our studies of glutamate interactions during aging suggest
that although the basal release of glutamate is maintained, the effects of gluta-
mate on other neurotransmitter systems may change as a consequence of aging
(Fig. 3). These findings would be in agreement with studies reporting a decrease
in the number of glutamate receptors (see above). Thus, this new perspective of
an interaction among different neurotransmitters provides a better understanding
of the neurochemical substrates of functional deficits during aging. The approach
developed in our laboratory to study in vivo endogenous interactions among
several neurotransmitters is proving to be a powerful tool to investigate the
changes of these interactions in specific circuits of the brain during aging.
G. Sego6ia et al. / Mechanisms of Ageing and De6elopment 122 (2001) 1–2922
5. Future perspectives
Studies on the interaction between different neurotransmitter systems (i.e. gluta-
mate and dopamine) in aging are providing new clues to understand the age-related
changes in specific circuits of the brain. Specifically the interaction between gluta-
mate, dopamine and GABA could be of interest to understand the functional
neurochemical substrates of aging as it has been useful to understand the neu-
ropathology of Parkinson’s disease. In fact, this type of interaction correlated with
behavioral parameters could provide significant advances in our understanding of
aging. This approach might also be the basis for the development of therapeutical
Fig. 3. Summary of the effects of aging on glutamate interactions in the nucleus accumbens: (A)
Glutamate released from glutamate terminals could act extrasynaptically on dopamine terminals
producing a release of dopamine that in turn could act on GABA neurons. (B) In aged rats, unaltered
glutamate release produces less dopamine and GABA responses (see Segovia, 1999 for details).
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tools aimed not only to compensate deficits of just one single neurotransmitter, but
to rebalance the possible deficits in the interaction of multiple neurotransmitters in
a specific circuit of the brain.
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